Margaret M FitzPatrick insider trades

Open-market stock purchases and sales by Margaret M FitzPatrick, Unknown at AN2 Therapeutics, Inc, from SEC Form 4 filings since Jul 21, 2021.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +225%.

Recent trades

DateStockTradeValue
Mar 19, 2026ANTX AN2 Therapeutics, IncBought (not open market)$44.8K
Mar 19, 2026ANTX AN2 Therapeutics, IncSold (not open market)$209K
Mar 19, 2026ANTX AN2 Therapeutics, IncBought (not open market)$40.5K
Mar 19, 2026ANTX AN2 Therapeutics, IncSold (not open market)$179K
Mar 19, 2026ANTX AN2 Therapeutics, IncBought (not open market)$92.8K
Mar 19, 2026ANTX AN2 Therapeutics, IncSold (not open market)$140K
Feb 20, 2026ANTX AN2 Therapeutics, IncBought (not open market)—

Companies traded

  • ANTX AN2 Therapeutics, Inc: 1 buy, last Mar 19, 2026
  • VTGN Vistagen Therapeutics, Inc: other filings, last Sep 9, 2025

Get free alerts when Margaret M FitzPatrick files a new trade →